Sign In
Buy NVAX
$10.20
-0.0100 (-0.0979%)
At Close: Jun 03, 2026
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novavax, Inc. - NVAX
04:35pm, Wednesday, 16'th Oct 2024
NEW YORK, NY / ACCESSWIRE / October 16, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Novavax, Inc. ("Novavax" or the "Company") (NASDAQ:NVAX). Such investors are advised to c
Novavax shares tumble after clinical hold on flu combo vaccine
03:33pm, Wednesday, 16'th Oct 2024
Novavax, Inc. (NASDAQ:NVAX) shares plummeted on Wednesday on news it faced a clinical hold on its CIC flu combination vaccine program after a serious adverse event (SAE) was reported in a Phase 2 tria
3 Vaccine Stocks to Watch as Flu Season Approaches
02:54pm, Wednesday, 16'th Oct 2024
Flu season is almost here, and there is a respiratory syncytial virus (RSV) vaccine update worth monitoring.
Novavax Stock Plunges as FDA Puts Hold on Vaccines Because of Safety Concerns
01:50pm, Wednesday, 16'th Oct 2024
Novavax (NVAX) shares plummeted nearly 20% Wednesday after the Food and Drug Administration (FDA) stopped research on the biotech firm's experimental combination COVID-19 and flu vaccine and standalon
Novavax, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - NVAX
12:45pm, Wednesday, 16'th Oct 2024
NEW YORK, NY / ACCESSWIRE / October 16, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Novavax, Inc. ("Novavax, Inc.") (NASDAQ:NVAX) concerning possible violation
Novavax says FDA put hold on combination Covid-flu shot and influenza vaccine; shares plunge
10:21am, Wednesday, 16'th Oct 2024
Novavax said the Food and Drug Administration has put a hold on its application for a combination shot targeting Covid and influenza and a standalone flu vaccine, sending shares of the company down sh
Novavax Stock Tumbles 20% as FDA Pauses Clinical Trial on Security Concerns
10:15am, Wednesday, 16'th Oct 2024
The regulator placed a clinical hold on its Covid-19-influenza combination vaccine after one person reported nerve damage.
Novavax's stock slides 16% after FDA puts clinical hold on COVID and flu vaccine candidates
09:12am, Wednesday, 16'th Oct 2024
Novavax Inc.'s stock tumbled 16% early Wednesday after the company said the FDA has placed a clinical hold on its COVID-19-and-flu combination and stand-alone flu vaccine candidates, following a case
Update on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial
08:14am, Wednesday, 16'th Oct 2024
GAITHERSBURG, Md. , Oct. 16, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that the U.S. Food and
US FDA places trials of two Novavax vaccines on hold
08:13am, Wednesday, 16'th Oct 2024
The U.S. Food and Drug Administration has placed a hold on clinical trials of Novavax's COVID and influenza combination vaccine, as well as standalone flu shot after a serious side-effect was seen in
Novavax (NVAX) Advances While Market Declines: Some Information for Investors
06:51pm, Thursday, 10'th Oct 2024
In the most recent trading session, Novavax (NVAX) closed at $12.91, indicating a +1.77% shift from the previous trading day.
EU authorizes Novavax's updated COVID vaccine targeting JN.1 strain
07:11am, Wednesday, 09'th Oct 2024
The European Union authorized Novavax's updated COVID vaccine targeting the JN.1 strain of coronavirus, the company said on Wednesday.
Novavax's Updated 2024-2025 Nuvaxovid™ COVID-19 Vaccine Receives Authorization in the EU
07:00am, Wednesday, 09'th Oct 2024
GAITHERSBURG, Md. , Oct. 9, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that the European Commis
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know
10:10am, Tuesday, 08'th Oct 2024
Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhile to examine what the stock has in store.
Novavax (NVAX) Stock Dips Amidst Volatility in Biotech Sector
03:31pm, Monday, 07'th Oct 2024
Shares of Novavax (NVAX, Financial), a biotechnology firm specializing in vaccine development, experienced a significant drop of 5.11%. The stock is currently priced at $12.92 with a trading volume of
